Cargando…
Evaluation of the quality of patient involvement in a patient-led analysis of the lived experience of a rare disease
BACKGROUND: Patients themselves are best placed to provide insights on the lived experience and to lead the analysis of such insights to bring the patient voice into peer-reviewed literature. In doing so, they can meet the authorship criteria for subsequent research publications. It is important to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214587/ https://www.ncbi.nlm.nih.gov/pubmed/37231525 http://dx.doi.org/10.1186/s40900-023-00445-2 |
_version_ | 1785047872533692416 |
---|---|
author | Lobban, Dawn Oliver, Jacqui Davio, Kelly Seddik, Kenza Porkess, Veronica |
author_facet | Lobban, Dawn Oliver, Jacqui Davio, Kelly Seddik, Kenza Porkess, Veronica |
author_sort | Lobban, Dawn |
collection | PubMed |
description | BACKGROUND: Patients themselves are best placed to provide insights on the lived experience and to lead the analysis of such insights to bring the patient voice into peer-reviewed literature. In doing so, they can meet the authorship criteria for subsequent research publications. It is important to evaluate patient engagement to identify ways to improve future collaborations. Here, we describe the approach taken during a patient-led and patient co-authored analysis of the lived experience of generalized myasthenia gravis, which may be applicable to other indications. We also assessed the quality of patient engagement throughout the research project. METHODS: We used self-reported experience surveys based on the Patient Focused Medicines Development Patient Engagement Quality Guidance criteria for assessing patient engagement. The surveys were adapted to focus on individual projects and assessed eight domains using a five-point Likert scale. In September 2020, we invited eight patient council members to complete a self-reported experience survey following qualitative lived experience data generation. We calculated the average experience score as a percentage of the maximum possible score. Patient authors (n = 1) and non-patient authors (n = 3) were invited to complete a similar survey in November 2021, with questions customized for relevance, to evaluate the authorship experience following publication of the research. RESULTS: Overall, patient council members had a positive experience of taking part in this study, with an average experience score of 90% (71.6/80.0; n = 8). The patient author and non-patient authors rated their authorship experience highly, with average experience scores of 92% (78.0/85.0) and 97% (63.3/65.0), respectively. There were key aspects that contributed to the overall project success (e.g., ensuring that all participants were aligned on the project objectives at the outset and understood their roles and responsibilities). We also identified elements of the approach that could be improved in future collaborations. CONCLUSION: In this patient-led analysis, patient council members, patient authors and non-patient authors had a positive experience of being involved in the project. We gained useful insights into elements that contributed to the project’s success and ways to improve future patient-led projects on the lived experience. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40900-023-00445-2. |
format | Online Article Text |
id | pubmed-10214587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102145872023-05-27 Evaluation of the quality of patient involvement in a patient-led analysis of the lived experience of a rare disease Lobban, Dawn Oliver, Jacqui Davio, Kelly Seddik, Kenza Porkess, Veronica Res Involv Engagem Comment BACKGROUND: Patients themselves are best placed to provide insights on the lived experience and to lead the analysis of such insights to bring the patient voice into peer-reviewed literature. In doing so, they can meet the authorship criteria for subsequent research publications. It is important to evaluate patient engagement to identify ways to improve future collaborations. Here, we describe the approach taken during a patient-led and patient co-authored analysis of the lived experience of generalized myasthenia gravis, which may be applicable to other indications. We also assessed the quality of patient engagement throughout the research project. METHODS: We used self-reported experience surveys based on the Patient Focused Medicines Development Patient Engagement Quality Guidance criteria for assessing patient engagement. The surveys were adapted to focus on individual projects and assessed eight domains using a five-point Likert scale. In September 2020, we invited eight patient council members to complete a self-reported experience survey following qualitative lived experience data generation. We calculated the average experience score as a percentage of the maximum possible score. Patient authors (n = 1) and non-patient authors (n = 3) were invited to complete a similar survey in November 2021, with questions customized for relevance, to evaluate the authorship experience following publication of the research. RESULTS: Overall, patient council members had a positive experience of taking part in this study, with an average experience score of 90% (71.6/80.0; n = 8). The patient author and non-patient authors rated their authorship experience highly, with average experience scores of 92% (78.0/85.0) and 97% (63.3/65.0), respectively. There were key aspects that contributed to the overall project success (e.g., ensuring that all participants were aligned on the project objectives at the outset and understood their roles and responsibilities). We also identified elements of the approach that could be improved in future collaborations. CONCLUSION: In this patient-led analysis, patient council members, patient authors and non-patient authors had a positive experience of being involved in the project. We gained useful insights into elements that contributed to the project’s success and ways to improve future patient-led projects on the lived experience. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40900-023-00445-2. BioMed Central 2023-05-25 /pmc/articles/PMC10214587/ /pubmed/37231525 http://dx.doi.org/10.1186/s40900-023-00445-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Comment Lobban, Dawn Oliver, Jacqui Davio, Kelly Seddik, Kenza Porkess, Veronica Evaluation of the quality of patient involvement in a patient-led analysis of the lived experience of a rare disease |
title | Evaluation of the quality of patient involvement in a patient-led analysis of the lived experience of a rare disease |
title_full | Evaluation of the quality of patient involvement in a patient-led analysis of the lived experience of a rare disease |
title_fullStr | Evaluation of the quality of patient involvement in a patient-led analysis of the lived experience of a rare disease |
title_full_unstemmed | Evaluation of the quality of patient involvement in a patient-led analysis of the lived experience of a rare disease |
title_short | Evaluation of the quality of patient involvement in a patient-led analysis of the lived experience of a rare disease |
title_sort | evaluation of the quality of patient involvement in a patient-led analysis of the lived experience of a rare disease |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214587/ https://www.ncbi.nlm.nih.gov/pubmed/37231525 http://dx.doi.org/10.1186/s40900-023-00445-2 |
work_keys_str_mv | AT lobbandawn evaluationofthequalityofpatientinvolvementinapatientledanalysisofthelivedexperienceofararedisease AT oliverjacqui evaluationofthequalityofpatientinvolvementinapatientledanalysisofthelivedexperienceofararedisease AT daviokelly evaluationofthequalityofpatientinvolvementinapatientledanalysisofthelivedexperienceofararedisease AT seddikkenza evaluationofthequalityofpatientinvolvementinapatientledanalysisofthelivedexperienceofararedisease AT porkessveronica evaluationofthequalityofpatientinvolvementinapatientledanalysisofthelivedexperienceofararedisease |